Eliot Forster

Chief Executive Officer, F-star Therapeutics, Inc.

Companies

Immatics N.V.Board member Mar 18, 2026 to now¹
Protalix Biotherapeutics IncBoard member Sep 15, 2023 to now²
F-star Therapeutics, Inc.Board member Nov 24, 2020 to Mar 9, 2023³
F-star Therapeutics, Inc.Chief executive officer Nov 24, 2020 to Mar 9, 2023³
F-star Therapeutics, Inc.President Nov 24, 2020 to Mar 9, 2023³

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Protalix Biotherapeutics Inc PLX7,500 shares⁴$20.4K at $2.71Sep 3, 2025
F-star Therapeutics, Inc.0 shares⁵Mar 8, 2023

As of each latest filing. The line shows shares held over time.

Recent filings

Sep 3, 2025Granted 7,500 shares of Protalix Biotherapeutics Inc⁴
Mar 8, 2023Returned to company 73,959 shares at $7.12 of F-star Therapeutics, Inc.⁵
Mar 8, 2023U 347,578 shares at $7.12 of F-star Therapeutics, Inc.⁵
Jul 29, 2022Exercised options 260,977 shares at $0.11 of F-star Therapeutics, Inc.⁶

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARImmatics N.V., Board member
2
SEC EDGARProtalix Biotherapeutics Inc, Board member
3
SEC EDGARF-star Therapeutics, Inc., Board member
4
SEC EDGARProtalix Biotherapeutics Inc shares after the filing of Sep 3, 2025
5
SEC EDGARF-star Therapeutics, Inc. shares after the filing of Mar 8, 2023
6
SEC EDGARForm 4 filed Aug 2, 2022